Cortalix B.V. sell "VHH antibody, nanobody, discovery services"

Cortalix delivers end-to-end nanobody discovery services built on proprietary synthetic and immune VHH libraries, guiding clients from target definition through to high-affinity lead candidates, including binder selection, affinity maturation, and engineering into multivalent or functional formats. The platform supports applications spanning oncology, immunotherapy, molecular imaging, and in vitro diagnostics.